← Back to Search

Transitional Care Stroke Intervention (TCSI) for Stroke

N/A
Waitlist Available
Led By Maureen Markle-Reid, PhD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights

Study Summary

This trial will test the effectiveness of a new coordinated care intervention for stroke patients transitioning from hospital to home. The intervention includes four components: discharge planning, home visits, monthly care conferences, and linkages to other services.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Any hospital readmission for any cause within 6 months
Secondary outcome measures
Change in anxiety
Change in caregiver strain
Change in community integration
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Transitional Care Stroke Intervention (TCSI)Experimental Treatment1 Intervention
Participants randomly assigned to the intervention group will be offered the intervention in addition to usual care provided by in-patient and outpatient stroke rehabilitation services. The TCSI is a 6-month stroke transitional care intervention, provided in addition to usual stroke care, that includes four core components: comprehensive hospital discharge plan, structured home visits and telephone support, monthly intraprofessional case conferences, and linkages to primary care and other healthcare and community services. The TCSI will be delivered by an interprofessional team of care providers at the study site, including an occupational therapist, registered nurse, speech language pathologist, physical therapist, and social worker from a hospital-based outpatient stroke rehabilitation setting.
Group II: ControlActive Control1 Intervention
Usual care provided by in-patient and out-patient stroke rehabilitation services.

Find a Location

Who is running the clinical trial?

Hamilton Health Sciences CorporationOTHER
366 Previous Clinical Trials
300,815 Total Patients Enrolled
11 Trials studying Stroke
48,740 Patients Enrolled for Stroke
Health Quality OntarioOTHER
5 Previous Clinical Trials
4,622 Total Patients Enrolled
Canadian Frailty NetworkOTHER
20 Previous Clinical Trials
20,811 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining slots for volunteers in this endeavor?

"According to the clinicaltrials.gov portal, this clinical trial has ceased recruitment as of April 6th 2022, although it first began recruiting patients on November 30th 2020. Fortunately, there are many other ongoing studies which still require participants - 1,044 in total at present."

Answered by AI
~21 spots leftby Apr 2025